UBS Group AG - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 27 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$2,000
-100.0%
2,000
-100.0%
0.00%
-100.0%
Q3 2016$5,622,000
-21.5%
5,000,000
-23.1%
0.00%
-40.0%
Q2 2016$7,166,000
+1.8%
6,500,0000.0%0.01%0.0%
Q1 2016$7,040,000
-6.7%
6,500,000
+8.3%
0.01%0.0%
Q4 2015$7,545,0006,000,0000.01%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 22,000,000$24,050,0002.14%
LINDEN ADVISORS LP 35,213,000$38,458,0001.43%
Bruce & Co., Inc. 5,500,000$5,775,0001.38%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,003,000$12,059,0001.23%
MACKAY SHIELDS LLC 16,877,000$18,442,0000.84%
ANGELO GORDON & CO., L.P. 11,000,000$11,983,0000.73%
IRON Financial LLC 535,000$585,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 18,400,000$20,111,0000.31%
Sonora Investment Management, LLC 1,430,000$1,556,598,0000.30%
SSI INVESTMENT MANAGEMENT LLC 2,830,000$3,084,0000.28%
View complete list of AMAG PHARMACEUTICALS INC shareholders